已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Endoscopic dacryocystorhinostomy with and without bicanalicular silicone tube in patients with a small lacrimal sac: a comparative study

泪囊鼻腔吻合术 泪囊 管(容器) 插管 医学 硅酮 外科 工程类 材料科学 机械工程 复合材料
作者
Bo Yu,B Mao,Yunhai Tu,M Wang,Wencan Wu
出处
期刊:Rhinology [Rhinology]
被引量:1
标识
DOI:10.4193/rhin22.151
摘要

Background: To establish whether bicanalicular silicone tube intubation is required during endoscopic dacryocystorhinostomy (En-DCR) for treating chronic dacryocystitis with a small lacrimal sac. Methods: In total, this study enrolled 264 patients diagnosed with unilateral chronic dacryocystitis with small lacrimal sacs via computed tomography-dacryocystography that underwent En-DCR from March 2016-September 2020. Patients were randomized into two treatment groups, with those in group A undergoing tubes intubation and those in group B not undergoing this procedure. The tubes were removed 3 months post-operation in group A. Surgical outcomes and related complication rates were then compared. Results: This study included 242 patients, including124 and 118 in groups A and B, respectively. At the three-month follow-up time point, 12.90% of patients in group A exhibited ostial granulation tissue, with this frequency with no differences observed in group B (11.86%). At 6 months post-surgery, 80.65% of patients in group A and 72.88% of patients in group B exhibited successful surgical outcomes, with no significant differences between groups. At 9 months postoperatively, the overall effective success rate was 60.74%, and the success rate was significantlyhigher in group A relative to group B (group A: 75.81%; group B: 44.92%). There were no failed patient outcomes observed as of the 12-month follow-up time point. Conclusions: While En-DCR-based treatment of chronic dacryocystitis in those with smalllacrimal sacs did not yield satisfactory outcomes with respect to the overall effective success rate, these results suggest that intraoperative intubation may improve success rates in long-term follow-up.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
简雨完成签到,获得积分10
刚刚
1秒前
2秒前
7秒前
亗sui发布了新的文献求助10
8秒前
9秒前
Orange应助粽子采纳,获得10
9秒前
SHIRO完成签到,获得积分10
11秒前
12秒前
pinecone发布了新的文献求助10
13秒前
15秒前
韩雨涛发布了新的文献求助10
15秒前
Lucas应助奋斗向日葵采纳,获得10
16秒前
亗sui完成签到,获得积分10
18秒前
simao完成签到,获得积分10
18秒前
jacob258完成签到 ,获得积分10
19秒前
20秒前
20秒前
20秒前
欢呼沅发布了新的文献求助10
25秒前
KamilahKupps发布了新的文献求助10
25秒前
会飞的猪qq完成签到,获得积分10
26秒前
小言完成签到,获得积分10
27秒前
嘟嘟雯完成签到 ,获得积分10
27秒前
28秒前
29秒前
门前海棠依旧完成签到,获得积分10
32秒前
yyyyy发布了新的文献求助10
33秒前
粽子发布了新的文献求助10
34秒前
顾矜应助pinecone采纳,获得10
35秒前
熊啊发布了新的文献求助10
36秒前
亿眼万年完成签到,获得积分10
37秒前
乔治韦斯莱完成签到 ,获得积分10
40秒前
CodeCraft应助韩雨涛采纳,获得10
41秒前
香蕉觅云应助欢呼沅采纳,获得10
42秒前
47秒前
GingerF应助聪慧的凡灵采纳,获得50
48秒前
刘丽完成签到 ,获得积分10
48秒前
49秒前
星辰大海应助FAYE采纳,获得10
49秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
First commercial application of ELCRES™ HTV150A film in Nichicon capacitors for AC-DC inverters: SABIC at PCIM Europe 1000
Feldspar inclusion dating of ceramics and burnt stones 1000
Digital and Social Media Marketing 600
Zeolites: From Fundamentals to Emerging Applications 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5987802
求助须知:如何正确求助?哪些是违规求助? 7407539
关于积分的说明 16048156
捐赠科研通 5128392
什么是DOI,文献DOI怎么找? 2751716
邀请新用户注册赠送积分活动 1722965
关于科研通互助平台的介绍 1627011